Summary of Purpose
Soluble epoxide hydrolase (sEH) is the metabolizing enzyme of epoxyeicosatrienoic acids (EETs), which may play a role in reducing neuroinflammation and regulating cerebral blood flow after subarachnoid hemorrhage (SAH). Hypotheses: Pharmacologic inhibition of the sEH enzyme is safe and will result in increased EETs availability in the blood and cerebrospinal fluid. This study is a double-blind,...Read More →
The following dates are available for this trial. Trial information last updated on 3 April 2018.
|1 May 2018||10 Oct 2017||1 Jun 2021||1 Dec 2021||1 Apr 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All
- Ross Martini, MD
- Laura Sissons-Ross